Insider Transactions in Q1 2025 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,840
-3.04%
|
$1,688,480
$122.62 P/Share
|
|
Jan 17
2025
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,559
+6.1%
|
-
|
|
Jan 17
2025
|
Robert Iannone EVP, G R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-3.12%
|
$266,082
$122.62 P/Share
|
|
Jan 17
2025
|
Robert Iannone EVP, G R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
7,506
+9.69%
|
-
|
|
Jan 17
2025
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,300
-5.22%
|
$402,600
$122.62 P/Share
|
|
Jan 17
2025
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,741
+10.91%
|
-
|
|
Jan 17
2025
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,641
+16.61%
|
-
|
|
Jan 17
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-5.1%
|
$166,530
$122.62 P/Share
|
|
Jan 17
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,533
+8.64%
|
-
|
|
Jan 17
2025
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,905
-4.88%
|
$232,410
$122.62 P/Share
|
|
Jan 17
2025
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,864
+13.06%
|
-
|
|
Jan 02
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.35%
|
$184,500
$123.43 P/Share
|